| Product Name | MF | CAS | Details |
|---|
| (6R,12S)-12-TERT-BUTYL-1,4,7-TRIOXADISPIRO[4.0.4.4]TETRADECANE | C15H26O3 | 1356398-02-1 | Details |
| 4-(4-METHYLBENZYLIDENEAMINO)PHENYL SULFONE | 200279-88-5 | Details |
| Anti-CAVIN1 antibody produced in rabbit | Details |
| Greiner MICROLON? 200 Immuno tube | Details |
| 2-(2-Pyridyl)ethyl-functionalized silica gel | Details |
| 2,2′-Biquinoline | C18H12N2 | 119-91-5 | Details |
| 8-(BENZYLAMINO)-1,3-DI-ME-7-(1-NAPHTHYLMETHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C25H23N5O2 | 309938-24-7 | Details |
| HGS Polyhedron molecular model | Details |
| 10,11-Dihydro-10-Hydroxycarbamazepine solution | C15H14N2O2 | 29331-92-8 | Details |
| 5-CHLORO-6-BETA-NITRO-5-ALPHA-CHOLESTAN-3-BETA-YL ACETATE | C29H48ClNO4 | Details |
| Anti-SARS CoV-2 RBD mutant N501Y Antibody, clone 8A6 | Details |
| ethyl 3-(dimethylamino)-3-oxo-2-phenylpropanoate | 26739-86-6 | Details |
| N-(2,6-DIFLUOROPHENYL)-2-METHYL-4-[5-METHYL-2-(METHYLSULFANYL)-3-THIENYL]-5-OXO-7-PHENYL-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBOXAMIDE | C29H26F2N2O2S2 | 441783-82-0 | Details |
| Scrambled 10Panx1 trifluoroacetate salt | C58H79N15O16 | 1315378-72-3 | Details |
| METHYL 2-OXO-2H-PYRIMIDO(2,1-B)(1,3)BENZOTHIAZOLE-4-CARBOXYLATE | C12H8N2O3S | 50290-39-6 | Details |
| 2-Fluorothiophenol | C6H5FS | 2557-78-0 | Details |
| Lithium niobate | LiNbO3 | 12031-63-9 | Details |
| Fumaric acid-2,3-d2 | C4H4O4 | 24461-32-3 | Details |
| N-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)-N-(2,4,5-TRIMETHOXYBENZYLIDENE)AMINE | C21H27N3O4 | 307347-95-1 | Details |
| 4-(2-((4-METHOXYANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 2,4-DICHLOROBENZOATE | C23H17Cl2N3O5 | 769148-22-3 | Details |
| ETHYL 7-(4-ACETYL-1-PIPERAZINYL)-6-F-4-HYDROXY(1,8)NAPHTHYRIDINE-3-CARBOXYLATE | C17H19FN4O4 | 882865-15-8 | Details |
| N,N'-BIS-(3-NITROBENZYLIDENE)-ETHYLENEDIAMINE | C16H14N4O4 | 81928-79-2 | Details |
| (2-OXOPROPANE-1,3-DIYL)BIS(TRIPHENYLPHOSPHONIUM) BROMIDE | C39H34BrOP2+ | 70307-60-7 | Details |
| K40-II CONNECTION KIT | Details |
| METHYL 4-{[((3R)-16-{[4-(METHOXYCARBONYL)BENZYL]OXY}-3-METHYL-1,7-DIOXO-3,4,5,6,7,8,9,10,11,12-DECAHYDRO-1H-2-BENZOXACYCLOTETRADECIN-14-YL)OXY]METHYL}BENZOATE | C36H40O9 | 1217835-81-8 | Details |
| N-Methyl-13C,d3-3-piperidinol | 1215321-72-4 | Details |
| Orbi-Shaker XL orbital shaker with flat mat platform | Details |
| Anti-MRI1 (296-310) antibody produced in rabbit | Details |
| Anti-PINLYP antibody produced in rabbit | Details |
| (5E)-5-(4-BUTOXY-3-METHOXYBENZYLIDENE)-2-(4-ETHOXYPHENYL)[1,3]THIAZOLO[3,2-B][1,2,4]TRIAZOL-6(5H)-ONE | C24H25N3O4S | 606951-75-1 | Details |
| 3-(4-BROMOPHENYL)-1-(2,5-DIMETHYLPHENYL)-3-HYDROXY-1H,2H,3H,5H,6H,7H-IMIDAZO[2,1-B][1,3]THIAZIN-4-IUM BROMIDE | C20H22Br2N2OS | 1104783-25-6 | Details |
| 5-(4-NITRO-BENZYLIDENE)-3-PHENYL-THIAZOLIDINE-2,4-DIONE | C16H10N2O4S | 92792-35-3 | Details |
| 4-((2-FLUOROBENZYLIDENE)AMINO)-5-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL | C16H13FN4S | 489462-49-9 | Details |
| Granzyme B Substrate VIII, Colorimetric | C28H38N6O11 | 216757-29-8 | Details |
| 1H-pyrrolo[3,2-b]pyridine | C7H6N2 | 272-49-1 | Details |
| Rectangular cell 100 mm | Details |
| 2-((4-ETHOXYBENZYLIDENE)AMINO)-6-METHYL-6H-1,3,4-THIADIAZIN-5-OL | C13H15N3O2S | 329698-90-0 | Details |
| Monoclonal Anti-ARFIP2, (N-terminal) antibody produced in mouse | Details |
| 2-(N-ETHYLANILINO)ETHYL N-(2-METHYL-5-NITROPHENYL)CARBAMATE | C18H21N3O4 | 198705-30-5 | Details |
| ISOBUTYL 2-[3-(4-BUTOXYBENZOYL)-2-(4-FLUOROPHENYL)-4-HYDROXY-5-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLATE | C30H31FN2O6S | 618081-96-2 | Details |
| 7-METHOXY-2-PHENYL-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,1'-CYCLOHEXANE] | C22H24N2O2 | 371234-56-9 | Details |
| N'-{(E)-[4-(BENZYLOXY)-3-METHOXYPHENYL]METHYLIDENE}-2-{[5-(4-CHLOROPHENYL)-4-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETOHYDRAZIDE | C31H26ClN5O3S | 303207-07-0 | Details |
| Pyrimidine-2-carboxamidoxime | C5H6N4O | 90993-49-0 | Details |
| N-(3-ACETYL-PHENYL)-2-PHENOXY-ACETAMIDE | C16H15NO3 | 303794-79-8 | Details |
| 4-Bromo-2-methoxybenzoic acid | C8H7BrO3 | 72135-36-5 | Details |
| 5-Acetyl-2,4-dimethylthiazole | C7H9NOS | 38205-60-6 | Details |
| Telmisartan for peak identification | C33H30N4O2 | 144701-48-4 | Details |
| 3,3'-DICHLORO-4,4'-DIHYDROXYAZOBENZENE | C12H8Cl2N2O2 | 200710-27-6 | Details |
| C6H11NO2 | 3105-95-1 | Details |
| 2-(2-PHENOXY-BENZYLIDENE)-BENZO(4,5)IMIDAZO(2,1-B)THIAZOL-3-ONE | C22H14N2O2S | 313965-85-4 | Details |
| 4-HYDROXY-N'-(2-HYDROXY-3-METHOXYBENZYLIDENE)BENZOHYDRAZIDE | C15H14N2O4 | 131536-58-8 | Details |
| 5-CHLORO-N-(5-METHYL-3-ISOXAZOLYL)-2-(2-PROPYNYLOXY)BENZAMIDE | C14H11ClN2O3 | 88812-90-2 | Details |
| 3-(3-CHLOROPHENYL)-2-(2,6-DICHLOROPHENYL)ACRYLONITRILE | C15H8Cl3N | 443779-25-7 | Details |
| 4-(TERT-BUTYLDIPHENYLSILYLOXY)-2-METHOXY-6-(TRITYLOXY)TETRAHYDROPYRAN | 195523-26-3 | Details |
| 2',4'-HEXADECANOXYLIDIDE | 199531-25-4 | Details |
| Anti-GSPT1 antibody produced in mouse | Details |
| N'-(3-((4-CHLOROBENZYL)OXY)BENZYLIDENE)-4-METHYLBENZOHYDRAZIDE | C22H19ClN2O2 | 883568-28-3 | Details |
| Sortase A, S. aureus, His-tag | Details |
| 4-CHLORO-3-(1-PIPERIDINYLSULFONYL)BENZOIC ACID | C12H14ClNO4S | 59210-74-1 | Details |
| ETHYL 3-(2,6-DIMETHYLMORPHOLINO)PROPIONATE | C11H21NO3 | 71172-51-5 | Details |
| 4-[(CHLOROMETHYL)SULFONYL]ANILINE | C7H8ClNO2S | 7569-24-6 | Details |
| L-(+)-THREO-3-PHENYL-BUTAN-2-OL | C10H14O | 52089-32-4 | Details |
| DIETHYL 2-(ACETYLAMINO)-2-CYANOPENTANEDIOATE | C12H18N2O5 | 892159-08-9 | Details |
| 4-BR-2-(2-(3,4,5-TRIMETHOXYBENZOYL)CARBOHYDRAZONOYL)PHENYL 3,4-DIMETHOXYBENZOATE | C26H25BrN2O8 | 883573-23-7 | Details |
| Anti-ERV3-1 | Details |
| 1-BENZOFURAN-2-CARBONITRILE | C9H5NO | 41717-32-2 | Details |
| GSK-3β Inhibitor XI | C18H15N5O3 | 626604-39-5 | Details |
| Anti-CDC23 antibody produced in rabbit | Details |
| ET 4-(3-(BENZYLOXY)-4-MEO-PHENYL)-6-ME-2-OXO-1,2,3,4-4H-5-PYRIMIDINECARBOXYLATE | C22H24N2O5 | 330834-97-4 | Details |
| 4-((4-HO-2-OXO-1-PR-1,2-2H-QUINOLINE-3-CARBONYL)-AMINO)-BENZOIC ACID ME ESTER | C21H20N2O5 | 304879-10-5 | Details |
| Hydroquinone | C6H6O2 | 123-31-9 | Details |
| Human coagulation factor VIII concentrate | 9001-27-8 | Details |
| Methyl 4-chloro-4-oxobutyrate | C5H7ClO3 | 1490-25-1 | Details |
| 2-CYCLOPROPYL-BUTAN-2-OL | C7H14O | 4435-58-9 | Details |
| Monoclonal Anti-CD4 azide free antibody produced in mouse | Details |
| Fluorescein o-acrylate | C23H14O6 | 193419-86-2 | Details |
| (±)-2-Methylbutyric acid | C5H10O2 | 116-53-0 | Details |
| 6-ETHYL-7-METHOXY-4-METHYL-CHROMEN-2-ONE | C13H14O3 | 109159-90-2 | Details |
| (2E)-N-butyl-3-(3,4,5-trimethoxyphenyl)-2-propenamide | C16H23NO4 | 910860-80-9 | Details |
| 2-CHLORO-N-(2-(2-(2-HYDROXY-5-NITROBENZYLIDENE)HYDRAZINO)-2-OXOETHYL)BENZAMIDE | C16H13ClN4O5 | 528573-50-4 | Details |
| 4-((AMINOCARBONYL)HYDRAZONO)-N-(4-METHOXYPHENYL)-7,7-DIMETHYL-6-OXOOCTANAMIDE | C18H26N4O4 | 883815-24-5 | Details |
| 3-(3-(2,4-DIMETHYLPHENYL)-6-OXO-1(6H)-PYRIDAZINYL)PROPANENITRILE | C15H15N3O | 358340-47-3 | Details |
| 4-Hydroxy-3-methoxyphenylglycol hemipiperazinium salt | C22H34N2O8 | 67423-45-4 | Details |
| Tungsten-chromium-vanadium steel | Details |
| (S)-()-Tetrahydro-2-furoic acid | C5H8O3 | 87392-07-2 | Details |
| TETRADECANOIC ACID (2-(1H-INDOL-3-YL)-ETHYL)-AMIDE | C24H38N2O | 21469-16-9 | Details |
| 4,5-DIMETHOXY-2-NITROPHENYLACETONITRILE | C10H10N2O4 | 17354-04-0 | Details |
| 17-(1,5-DIMETHYL-HEXYL)-10,13-DIMETHYL-DODECAHYDRO-1H-CYCLOPENTA(A)PHENANTHRENE | Details |
| Anti-ZNF548 antibody produced in rabbit | Details |
| Anti-FCGR2A/C Antibody, clone 11B6 | Details |
| 4-({4-[(4-BROMOBENZOYL)OXY]PHENYL}SULFONYL)PHENYL 4-BROMOBENZOATE | 883836-35-9 | Details |
| (5Z)-3-SEC-BUTYL-5-{[3-(3-FLUORO-4-PROPOXYPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-2-THIOXO-1,3-THIAZOLIDIN-4-ONE | C26H26FN3O2S2 | 623936-22-1 | Details |
| 2,5-Diaminopyridine dihydrochloride | C5H9Cl2N3 | 26878-35-3 | Details |
| 3,6-Dichloropyridazine | C4H2Cl2N2 | 141-30-0 | Details |
| DIETHYL 7-OXATRICYCLO(4.1.0)-HEPTANE-3,4-DICARBOXYLATE | 198076-82-3 | Details |
| α-Methoxy-α-(trifluoromethyl)phenylacetyl chloride | C10H8ClF3O2 | 64312-89-6 | Details |
| Anti-Apobec1 Antibody | Details |
| N-(3,5-DIMETHOXYPHENYL)-2-{[3-(4-METHOXYPHENYL)-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL]SULFANYL}ACETAMIDE | C27H27N3O5S2 | 477329-44-5 | Details |
| Chloro[di(1-adamantyl)-2-dimethylaminophenylphosphine]gold(I) | C28H41AuClNP | 2043952-58-3 | Details |
| methyl 2-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl ether | C10H10N2O2 | 18233-20-0 | Details |
| Product Total： Product Page： | ||||
| 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 | ||||